SEI Investments
MXCT icon

SEI Investments’s MaxCyte MXCT Stock Holding History

SEI Investments’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-70,706
Closed -$296K – 2705
2024
Q1 		$296K Sell
70,706
-2,754
-4% -$12.9K ﹤0.01% 2310
2023
Q4 		$345K Sell
73,460
-1,488
-2% -$5.79K ﹤0.01% 2258
2023
Q3 		$234K Sell
74,948
-19,234
-20% -$77.3K ﹤0.01% 2391
2023
Q2 		$432K Sell
94,182
-5,648
-6% -$26K ﹤0.01% 2197
2023
Q1 		$494K Buy
99,830
+80,253
+410% +$395K ﹤0.01% 2136
2022
Q4 		$107K Sell
19,577
-68,140
-78% -$418K ﹤0.01% 2435
2022
Q3 		$570K Sell
87,717
-1,563
-2% -$8.72K ﹤0.01% 2022
2022
Q2 		$422K Buy
+89,280
New +$440K ﹤0.01% 2171

Other funds holding MXCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

SEI Investments's MXCT Position: Q2 2024 in Review

SEI Investments sold out of MaxCyte (MXCT) in Q2 2024, closing a stake of 70,706 shares — an estimated $296K sold.

SEI Investments first reported a position in MXCT in Q2 2022 and held it in 8 quarters. The position peaked at $570K in Q3 2022. 114 funds tracked by Wall St. Rank hold MXCT as of Q2 2024.

  • SEI Investments reported no remaining MaxCyte position as of Q2 2024 after selling out during the quarter.
  • SEI Investments sold 70,706 MaxCyte shares in Q2 2024, an estimated $296K.
  • SEI Investments first reported a position in MaxCyte in Q2 2022 and held it in 8 quarters.
  • SEI Investments's MaxCyte position peaked at $570K in Q3 2022.
  • 114 funds tracked by Wall St. Rank held MaxCyte as of Q2 2024.

Based on SEI Investments's 13F filing for Q2 2024, filed 13 Aug 2024.